Alveolar ridge bone augmentation using gene-activated bone substitute: long-term clinical follow-up
Thus, the gene-activated bone substitute has proven its safety and long-term effectiveness in jaw bone grafting for up to 7 years, and it can be used to treat patients requiring dental implantation.
Authors
- E.V. Presnyakov (ORCID: https://orcid.org/0000-0003-1546-5129)
- N. Redko (ORCID: https://orcid.org/0000-0001-7807-9351)
- G. A Volozhin (ORCID: https://orcid.org/0000-0002-0205-2811)
- A. Drobyshev (ORCID: https://orcid.org/0000-0002-1710-6923)
- I. Y Bozo (ORCID: https://orcid.org/0000-0002-0138-5614)
- Roman V. Deev (ORCID: https://orcid.org/0000-0001-8389-3841)
Institutions
- Russian Scientific Center of Surgery (RU)
- Atotech (United States) (US)
Publication Details
- Journal
- Stomatology
- Published
- 2025-12-11
- DOI
- https://doi.org/10.17116/stomat202510406256
- Primary Topic
- Dental Implant Techniques and Outcomes
- Type
- article
- Field-Weighted Citation Impact
- 0.00